Stonebridge Financial Group’s Boston Scientific BSX Stock Holding History

Stonebridge Financial Group’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$304K	Buy	+7,146	New	+$388K	0.04%	222

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Stonebridge Financial Group's BSX Position: Q2 2026 in Review

Stonebridge Financial Group opened a new position in Boston Scientific (BSX) in Q2 2026: 7,146 shares worth $304K. The stake represents 0.04% of the portfolio and ranks #222 among its holdings.

1,381 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Stonebridge Financial Group held 7,146 shares of Boston Scientific worth $304K as of Q2 2026.
Boston Scientific was a new Stonebridge Financial Group position in Q2 2026.
Boston Scientific made up 0.04% of Stonebridge Financial Group's portfolio in Q2 2026, its #222 holding.
1,381 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Stonebridge Financial Group's 13F filing for Q2 2026, filed 13 Aug 2026.